Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.26.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.129 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used